Posted on 11/23/20
Is Pfizer Stock A Good Bet On Coronavirus Vaccines?
Pfizer (NYSE:PFE) and its German partner BioNTech (NASDAQ:BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired . . .
Posted on 11/23/20
Is Pfizer and BioNTech's Potential mRNA Coronavirus Vaccine Revolutionary?
Pfizer (NYSE:PFE) and its German partner BioNTech (NASDAQ:BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired . . .
Posted on 11/23/20
Is Inovio Back in the Coronavirus Vaccine Race?
Inovio Pharmaceuticals (NASDAQ:INO) investors can breathe a little easier this week after the U.S. Food and Drug Administration lifted a partial clinical hold on the planned . . .
Posted on 11/23/20
CVS Health: The Numbers Simply Don't Add Up
SummaryAs a dominant player along the pharmacy value chain, CVS has proven to be a resilient EVA generator through thick and thin.The company is making good . . .
Posted on 11/23/20
What's the Outlook for Moderna Stock?
On Nov. 16, large-cap biotech Moderna (NASDAQ:MRNA) reported that its experimental messenger RNA (mRNA) vaccine (mRNA-1273) is nearly 95% effective at immunizing patients against COVID-19. This . . .
Posted on 11/23/20
Can the Moderna and BioNTech Bulls Keep Running?
Positive results from clinical trials with their coronavirus vaccine candidates have pushed shares of Moderna (NASDAQ:MRNA) and BioNTech (NASDAQ:BNTX) into the clouds. Neither of these companies . . .
Posted on 11/23/20
Warren Buffett Is Throwing Billions at This Stock. Should You Buy, Too?
Berkshire Hathaway (NYSE:BRK-B)(NYSE:BRK-A) chairman and CEO Warren Buffett knows a thing or two about investing, to put it mildly. His investment prowess has helped Berkshire stock . . .
Posted on 11/23/20
Better Coronavirus Stock: Moderna or Novavax?
Does big pharma dominate the coronavirus vaccine race? It might seem that way. Of the five COVID-19 vaccine candidates in late-stage testing that could be players . . .
Posted on 11/23/20
The Big Thing to Know About Moderna's COVID Vaccine Results
Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) were the first drugmakers to announce interim efficacy results from a late-stage study of their coronavirus vaccine candidate. Moderna(NASDAQ:MRNA) had its . . .
Posted on 11/23/20
Is Moderna a Good Stock to Buy Right Now?
Moderna(NASDAQ:MRNA) recently announced an impressive efficacy of 94.5% from a late-stage study of coronavirus vaccine candidate mRNA-1273. The biotech stock jumped on the good news, but . . .
Posted on 11/23/20
Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA
There's a new coronavirus treatment option that will go a long way to prevent hospitals from getting swarmed with severe patients this winter. On Saturday night, . . .
Posted on 11/23/20
Sarepta Therapeutics Named One of The Boston Globe’s Top Places to Work 2020
CAMBRIDGE, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has . . .
Posted on 11/23/20
Matinas BioPharma Awarded up to $3.75M from the Cystic Fibrosis Foundation
BEDMINSTER, N.J., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to . . .
Posted on 11/23/20
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
F-star Therapeutics, Inc., (Nasdaq: FSTX, as of November 23, 2020) a clinical-stage immuno-oncology company determined to transform the lives of patients with cancer through the development . . .
Posted on 11/23/20
Maryland Records Second-Largest Daily Amount of New Coronavirus Cases
Maryland recorded an additional 2,353 confirmed coronavirus cases on Friday, the second largest daily number of new cases after the state recorded 2,910 cases on Thursday, . . .
Posted on 11/23/20
A Q&A with Dr. Samuel Hahn with MD Center for Facial Plastic Surgery
The pandemic has had a profound impact on the way the healthcare industry has operated. We sat down with
Posted on 11/20/20
Peak Physical Therapy & Sports Performance Expands Clinic at the Wolves Den Sports Complex in Pembroke
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, has . . .
Posted on 11/20/20
Tufts Health Plan Named a 2020 Top Place to Work by The Boston Globe
Tufts Health Plan has been named one of the Top Places to Work in Massachusetts in the 13th annual employee-based survey from The Boston Globe. Tufts . . .
Posted on 11/20/20
Oragenics Prices $5.25 Million Common Stock Offering
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN), a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, today announced . . .
Posted on 11/20/20
AVROBIO Prices of Underwritten Public Offering of $75 Million of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced the pricing of an underwritten public offering of 5,000,000 shares of its . . .
Posted on 11/20/20
Precision Medicine Group Secures Major Investment from Blackstone
NEW YORK & BETHESDA, Md.--(BUSINESS WIRE)--Precision Medicine Group and Blackstone (NYSE: BX) today announced that PMG, a leading next-generation provider of drug development and commercialization services, has . . .
Posted on 11/20/20
Sarepta Therapeutics Named One of The Boston Globe’s Top Places to Work 2020
CAMBRIDGE, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has . . .
Posted on 11/20/20
BioRestorative Therapies Emerges from Chapter 11 Reorganization
MELVILLE, N.Y., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc.(OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced today that its amended . . .
Posted on 11/20/20
Sorrento CEO Henry Ji on How the Company Got Its Start
In this video from Motley Fool Live, which was recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento Therapeutics(NASDAQ:SRNE), talks about how the . . .
Posted on 11/20/20
How Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?
In this video from Motley Fool Live recorded on Nov. 12, executives from Sorrento Therapeutics (NASDAQ:SRNE) talk about how the company's COVID-19 therapeutic antibodies -- STI-1499 . . .

